Bone Marrow Transplantation and CAR T-cell therapy
Target Audience:
Hematologists, oncologists
Type of Education Activity:
Offsite observership at Sheba – individual
The observership will include the following treatments:
Autologous and allogeneic stem cell transplantations from sibling, matched, and mismatched donors
Non-T-depleted-haploidentical transplants and cord blood transplantation for all types of hematological malignancies as well as non-malignant hematological disorders
Advanced cellular-based immunotherapies, including donor lymphocyte infusions and Chimeric antigen receptor-based therapies for lymphoma, myeloma, and also acute leukemia, mainly lymphatic but also a subtype of acute myelogenous leukemia.
Level: Basic – Advanced
Target Audience: Doctors/Physicians
Minimum Number of Participants: 1
Type of Activity: Offsite, Digital
Level: Basic – Advanced
CONTACT US
Number of participants:
Offsite observership at Sheba: 1-2
Duration:
Offsite observership at Sheba: 2-4 weeks
Objectives:
Describing the indications and contraindications for BMT
Describing the indications and contraindications for CAR T-cell therapy
Reviewing the short and long-term complications of BMT and CAR T-cell therapy
Reviewing the latest protocols for BMT and CAR T-cell therapy
Main topics
Indications for BMT
CAR T-cell therapy principles and practice
BMT and CAR T-cell therapy case discussions
Early complications post BMT
Early complications post CAR T-cell therapy
Management of GvHD
Management of long-term complications
Training Methodology:
Ward rounds
Outpatient and day care unit management – observation
Clinical case discussions
* The course structure serves as a guideline and can be modified and tailored according to the needs and objectives of each client.
Target Audience: 
Type of Education Activity: 
Level: 
Number of participants: 
Duration: 
Basic – Advanced
Digital | Offsite
